Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Allen

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1974
Lactose immobilized on stainless steel and other dense metal and metal oxide supportsM Charles, R W Coughlin, B R Allen, et al.
Clinical and Experimental Dermatology|July 1, 1986
Skin immunofluorescence in the diagnosis of primary bullous diseases--a review of 279 casesP D Maurice, B R Allen, D W Marriott, et al.
Clinical and Experimental Dermatology|November 1, 1986
Sulconazole versus clotrimazole in the treatment of dermatophytosisD H McVie, S Littlewood, B R Allen, et al.
Lancet (London, England)|March 2, 1985
Thalidomide, orogenital ulcers, and risk of teratogenicityS Jenkins, R J Powell, B R Allen, et al.
The British Journal of Dermatology|November 1, 1987
The effects of dietary supplementation with fish oil in patients with psoriasisP D Maurice, B R Allen, A S Barkley, et al.
The British Journal of Dermatology|July 1, 1975
The effect of treatment on plasma uroporphyrin levels in cutaneous hepatic porphyriaB R Allen, S Parker, G G Thompson, et al.
The British Journal of Dermatology|July 1, 1978
Immunofluorescent and serological findings in 110 patients with suspected bullous skin disorders [proceedings]W G Reeves, B R Allen, M Crone, et al.
Lancet (London, England)|December 22, 1984
Thalidomide in severe orogenital ulcerationJ S Jenkins, R J Powell, B R Allen, et al.
The British Journal of Dermatology|July 1, 1985
Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomideR J Powell, B R Allen, J S Jenkins, et al.
Archives of Disease in Childhood|November 13, 2003
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patientsB R Allen, M Lakhanpaul, A Morris, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|January 1, 1974
Lactose immobilized on stainless steel and other dense metal and metal oxide supportsM Charles, R W Coughlin, B R Allen, et al.
Clinical and Experimental Dermatology|July 1, 1986
Skin immunofluorescence in the diagnosis of primary bullous diseases--a review of 279 casesP D Maurice, B R Allen, D W Marriott, et al.
Clinical and Experimental Dermatology|November 1, 1986
Sulconazole versus clotrimazole in the treatment of dermatophytosisD H McVie, S Littlewood, B R Allen, et al.
Lancet (London, England)|March 2, 1985
Thalidomide, orogenital ulcers, and risk of teratogenicityS Jenkins, R J Powell, B R Allen, et al.
The British Journal of Dermatology|November 1, 1987
The effects of dietary supplementation with fish oil in patients with psoriasisP D Maurice, B R Allen, A S Barkley, et al.
The British Journal of Dermatology|July 1, 1975
The effect of treatment on plasma uroporphyrin levels in cutaneous hepatic porphyriaB R Allen, S Parker, G G Thompson, et al.
The British Journal of Dermatology|July 1, 1978
Immunofluorescent and serological findings in 110 patients with suspected bullous skin disorders [proceedings]W G Reeves, B R Allen, M Crone, et al.
Lancet (London, England)|December 22, 1984
Thalidomide in severe orogenital ulcerationJ S Jenkins, R J Powell, B R Allen, et al.
The British Journal of Dermatology|July 1, 1985
Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomideR J Powell, B R Allen, J S Jenkins, et al.
Archives of Disease in Childhood|November 13, 2003
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patientsB R Allen, M Lakhanpaul, A Morris, et al.
Pageof 7